Contraindicated use of modern contraceptives among mothers from a Pelotas Birth Cohort

Detalhes bibliográficos
Autor(a) principal: Houvèssou, Gbènankpon Mathias
Data de Publicação: 2024
Outros Autores: Farías-Antúnez, Simone, Bertoldi, Andréa D., Silveira, Mariângela Freitas da
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista de Saúde Pública
Texto Completo: https://www.revistas.usp.br/rsp/article/view/222330
Resumo: OBJECTIVE: To describe the prevalence of contraindicated use of combined hormonal contraceptives, progesterone-only contraceptives, and intrauterine devices in mothers participating in the 2015 Pelotas Birth Cohort according to the WHO medical eligibility criteria. METHODS: The biological mothers of children belonging to the 2015 Pelotas birth cohort who attended the 48-month follow-up were studied. The 48-month follow-up data were collected from January 1, 2019, to December 31, 2019. Contraindicated use of modern contraceptives was considered to occur when these women presented at least one of the contraindications for the use of modern contraceptives and were using these methods. The prevalence of contraindicated use was calculated according to each independent variable and their respective 95% confidence intervals (95%CI). RESULTS: The analyzed sample consisted of 3,053 women who used any modern contraceptive method. The prevalence of contraindicated use of modern contraceptives totaled 25.9% (95%CI: 24.4–27.5). Combined hormonal contraceptives showed the highest prevalence of contraindicated use (52.1%; 95%CI: 49.3–54.8). The prevalence of contraindicated use of modern contraceptives methods was greater in women with family income between one and three minimum wages, a 25–30 kg/m2 body mass index, indication by a gynecologist for the used method, and purchasing the contraceptive method at a pharmacy. The higher the women’s education, the lower the prevalence of inappropriate use of modern contraceptives. CONCLUSION: In total, one in four women used modern contraceptives despite showing at least one contraindication. Policies regarding women’s reproductive health should be strengthened.
id USP-23_8ef2952568d47b6dca08b6e0fe1c8a45
oai_identifier_str oai:revistas.usp.br:article/222330
network_acronym_str USP-23
network_name_str Revista de Saúde Pública
repository_id_str
spelling Contraindicated use of modern contraceptives among mothers from a Pelotas Birth CohortContraceptive AgentsContraindicationsProgesteroneContraceptives, Oral, CombinedIntrauterine DevicesOBJECTIVE: To describe the prevalence of contraindicated use of combined hormonal contraceptives, progesterone-only contraceptives, and intrauterine devices in mothers participating in the 2015 Pelotas Birth Cohort according to the WHO medical eligibility criteria. METHODS: The biological mothers of children belonging to the 2015 Pelotas birth cohort who attended the 48-month follow-up were studied. The 48-month follow-up data were collected from January 1, 2019, to December 31, 2019. Contraindicated use of modern contraceptives was considered to occur when these women presented at least one of the contraindications for the use of modern contraceptives and were using these methods. The prevalence of contraindicated use was calculated according to each independent variable and their respective 95% confidence intervals (95%CI). RESULTS: The analyzed sample consisted of 3,053 women who used any modern contraceptive method. The prevalence of contraindicated use of modern contraceptives totaled 25.9% (95%CI: 24.4–27.5). Combined hormonal contraceptives showed the highest prevalence of contraindicated use (52.1%; 95%CI: 49.3–54.8). The prevalence of contraindicated use of modern contraceptives methods was greater in women with family income between one and three minimum wages, a 25–30 kg/m2 body mass index, indication by a gynecologist for the used method, and purchasing the contraceptive method at a pharmacy. The higher the women’s education, the lower the prevalence of inappropriate use of modern contraceptives. CONCLUSION: In total, one in four women used modern contraceptives despite showing at least one contraindication. Policies regarding women’s reproductive health should be strengthened.Universidade de São Paulo. Faculdade de Saúde Pública2024-02-21info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/xmlapplication/pdfhttps://www.revistas.usp.br/rsp/article/view/22233010.11606/s1518-8787.2024058005585Revista de Saúde Pública; v. 58 n. 1 (2024); 2Revista de Saúde Pública; Vol. 58 Núm. 1 (2024); 2Revista de Saúde Pública; Vol. 58 No. 1 (2024); 21518-87870034-8910reponame:Revista de Saúde Públicainstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/rsp/article/view/222330/202989https://www.revistas.usp.br/rsp/article/view/222330/202990Copyright (c) 2024 Gbènankpon Mathias Houvèssou, Simone Farías-Antúnez, Andréa D. Bertoldi, Mariângela Freitas da Silveirahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessHouvèssou, Gbènankpon MathiasFarías-Antúnez, SimoneBertoldi, Andréa D.Silveira, Mariângela Freitas daHouvèssou, Gbènankpon MathiasFarías-Antúnez, SimoneBertoldi, Andréa D.Silveira, Mariângela Freitas daHouvèssou, Gbènankpon MathiasFarías-Antúnez, SimoneBertoldi, Andréa D.Silveira, Mariângela Freitas da2024-04-30T18:42:01Zoai:revistas.usp.br:article/222330Revistahttps://www.revistas.usp.br/rsp/indexONGhttps://www.revistas.usp.br/rsp/oairevsp@org.usp.br||revsp1@usp.br1518-87870034-8910opendoar:2024-04-30T18:42:01Revista de Saúde Pública - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Contraindicated use of modern contraceptives among mothers from a Pelotas Birth Cohort
title Contraindicated use of modern contraceptives among mothers from a Pelotas Birth Cohort
spellingShingle Contraindicated use of modern contraceptives among mothers from a Pelotas Birth Cohort
Houvèssou, Gbènankpon Mathias
Contraceptive Agents
Contraindications
Progesterone
Contraceptives, Oral, Combined
Intrauterine Devices
title_short Contraindicated use of modern contraceptives among mothers from a Pelotas Birth Cohort
title_full Contraindicated use of modern contraceptives among mothers from a Pelotas Birth Cohort
title_fullStr Contraindicated use of modern contraceptives among mothers from a Pelotas Birth Cohort
title_full_unstemmed Contraindicated use of modern contraceptives among mothers from a Pelotas Birth Cohort
title_sort Contraindicated use of modern contraceptives among mothers from a Pelotas Birth Cohort
author Houvèssou, Gbènankpon Mathias
author_facet Houvèssou, Gbènankpon Mathias
Farías-Antúnez, Simone
Bertoldi, Andréa D.
Silveira, Mariângela Freitas da
author_role author
author2 Farías-Antúnez, Simone
Bertoldi, Andréa D.
Silveira, Mariângela Freitas da
author2_role author
author
author
dc.contributor.author.fl_str_mv Houvèssou, Gbènankpon Mathias
Farías-Antúnez, Simone
Bertoldi, Andréa D.
Silveira, Mariângela Freitas da
Houvèssou, Gbènankpon Mathias
Farías-Antúnez, Simone
Bertoldi, Andréa D.
Silveira, Mariângela Freitas da
Houvèssou, Gbènankpon Mathias
Farías-Antúnez, Simone
Bertoldi, Andréa D.
Silveira, Mariângela Freitas da
dc.subject.por.fl_str_mv Contraceptive Agents
Contraindications
Progesterone
Contraceptives, Oral, Combined
Intrauterine Devices
topic Contraceptive Agents
Contraindications
Progesterone
Contraceptives, Oral, Combined
Intrauterine Devices
description OBJECTIVE: To describe the prevalence of contraindicated use of combined hormonal contraceptives, progesterone-only contraceptives, and intrauterine devices in mothers participating in the 2015 Pelotas Birth Cohort according to the WHO medical eligibility criteria. METHODS: The biological mothers of children belonging to the 2015 Pelotas birth cohort who attended the 48-month follow-up were studied. The 48-month follow-up data were collected from January 1, 2019, to December 31, 2019. Contraindicated use of modern contraceptives was considered to occur when these women presented at least one of the contraindications for the use of modern contraceptives and were using these methods. The prevalence of contraindicated use was calculated according to each independent variable and their respective 95% confidence intervals (95%CI). RESULTS: The analyzed sample consisted of 3,053 women who used any modern contraceptive method. The prevalence of contraindicated use of modern contraceptives totaled 25.9% (95%CI: 24.4–27.5). Combined hormonal contraceptives showed the highest prevalence of contraindicated use (52.1%; 95%CI: 49.3–54.8). The prevalence of contraindicated use of modern contraceptives methods was greater in women with family income between one and three minimum wages, a 25–30 kg/m2 body mass index, indication by a gynecologist for the used method, and purchasing the contraceptive method at a pharmacy. The higher the women’s education, the lower the prevalence of inappropriate use of modern contraceptives. CONCLUSION: In total, one in four women used modern contraceptives despite showing at least one contraindication. Policies regarding women’s reproductive health should be strengthened.
publishDate 2024
dc.date.none.fl_str_mv 2024-02-21
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/rsp/article/view/222330
10.11606/s1518-8787.2024058005585
url https://www.revistas.usp.br/rsp/article/view/222330
identifier_str_mv 10.11606/s1518-8787.2024058005585
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/rsp/article/view/222330/202989
https://www.revistas.usp.br/rsp/article/view/222330/202990
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/xml
application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Saúde Pública
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Saúde Pública
dc.source.none.fl_str_mv Revista de Saúde Pública; v. 58 n. 1 (2024); 2
Revista de Saúde Pública; Vol. 58 Núm. 1 (2024); 2
Revista de Saúde Pública; Vol. 58 No. 1 (2024); 2
1518-8787
0034-8910
reponame:Revista de Saúde Pública
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Revista de Saúde Pública
collection Revista de Saúde Pública
repository.name.fl_str_mv Revista de Saúde Pública - Universidade de São Paulo (USP)
repository.mail.fl_str_mv revsp@org.usp.br||revsp1@usp.br
_version_ 1800221766385139712